Research
-
Fighting cancer is in his blood—and ours
June 1, 2024Baylor Scott & White Health chief of oncology demonstrates that immunotherapy combined with chemotherapy and radiation prior to surgical resection of a tumor, is safe while also demonstrating how to track tumor responses utilizing a novel blood test. Dr. Ronan Kelly · Chief of oncology for Baylor Scott & White Health in North Texas Understanding […]Learn more Fighting cancer is in his blood—and ours -
New hope for Alzheimer’s patients
September 1, 2023BSW AT&T Memory Center director Cindy Marshall, MD, answers questions about new FDA drug approval.Learn more New hope for Alzheimer’s patients -
Texas Immuno-Oncology Biorepository launches inaugural research study
March 1, 2023Much of our current information about how to treat cancer comes from clinical trials; however, there are limits to what we can learn from trials alone. Ronan Kelly, MD, chief of oncology at Baylor Scott & White Charles A. Sammons Cancer Center and the W.W. Caruth, Jr. Chair in Immunology at Baylor University Medical Center, […]Learn more Texas Immuno-Oncology Biorepository launches inaugural research study -
Physician profile: Byron Cryer, MD
December 1, 2022Byron Cryer, MD, chief of internal medicine at BUMC, shares his vision for patient care, physician training and the impact of philanthropy.Learn more Physician profile: Byron Cryer, MD -
Esophageal cancer breakthrough gets FDA approval
June 1, 2021Dr. Ronan Kelly authors study released in The New England Journal of Medicine on a global phase III clinical trial at 170 sites including Baylor University Medical Center in Dallas. The results of a study published in April in The New England Journal of Medicine (NEJM) found that the immunotherapy drug nivolumab (Opdivo®), if used […]Learn more Esophageal cancer breakthrough gets FDA approval -
The answer to successfully treating cancer lies within
March 1, 2021Baylor Scott & White Health fosters transformational immunology research that can lead to earlier diagnoses and novel immunotherapies through the new Texas Immuno-Oncology Biorepository (TIOB).Learn more The answer to successfully treating cancer lies within -
Drawing on the strength of the human body for innovative clinical trials
June 1, 2019Dr. Ronan Kelly, new chief of oncology at Baylor Scott & White Health – North Texas, is poised to help cancer patients benefit through greater access to novel research investigating next-generation immunotherapies.Learn more Drawing on the strength of the human body for innovative clinical trials -
Giving with Grateful Hearts
March 1, 2019Thinking globally and acting locally has one Dallas family on a mission to enhance healthcare For the Gupta family, a successful life is one filled with balance. Family, spirituality, personal health and community are all important to Satish and Yasmin Gupta, who are successful entrepreneurs as founders and owners of SB International Inc., a manufacturer […]Learn more Giving with Grateful Hearts




